Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry

Published:2018-11 Issue: Volume:271 Page:68-74
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Boriani Giuseppe,Proietti Marco,Laroche Cécile,Diemberger Igor,Popescu Mircea Ioachim^ORCID,Riahi Sam^ORCID,Shantsila Alena,Dan Gheorghe-Andrei,Tavazzi Luigi,Maggioni Aldo P.,Lip Gregory Y.H.

Funder

Abbott Vascular

Amgen Cardiovascular

AstraZeneca

Bayer AG

Boehringer Ingelheim

Boston Scientific

The Bristol Myers Squibb and Pfizer Alliance

Daiichi Sankyo Europe GmbH

The Alliance Daiichi Sankyo Europe GmbH

Eli Lilly and Company

Edwards

Gedeon Richter

Menarini Int. Op

MSD-Merck & Co

Novartis Pharma

ResMed

Sanofi

SERVIER

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur. Heart J.,2016

2. The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems;Boriani;Eur. Heart J.,2006

3. Heart disease and stroke statistics—2017 update: a report from the American heart association;Benjamin;Circulation,2017

4. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) pilot general registry;Lip;Europace,2014

5. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation general registry pilot phase (EORP-AF pilot registry);Lip;Eur. Heart J.,2014

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tratamiento anticoagulante oral en la fibrilación auricular: AFIRMA, el estudio de vida real realizado mediante procesamiento de lenguaje natural y aprendizaje automático;Revista Clínica Española;2024-08

2. Oral anticoagulant treatment in atrial fibrillation: the AFIRMA real-world study using natural language processing and machine learning;Revista Clínica Española (English Edition);2024-08

3. Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS;Europace;2024-06-29

4. Global and regional burden of ischemic stroke associated with atrial fibrillation, 2009–2019;Preventive Medicine;2023-08

5. Incidence and Predictors of Switching and Dose Change of Direct Oral Anticoagulants among Elderly Patients with Nonvalvular Atrial Fibrillation: A 5-Year Analysis of a Large Administrative Database;Journal of Clinical Medicine;2023-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3